Cullen/Frost Bankers, Inc. Amgen Inc Transaction History

Cullen/Frost Bankers, Inc.

$6.83 Billion
Q2 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 88,640 shares of AMGN stock, worth $28 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

88,640

Previous 88,505 0.15%

Holding current value

$28 Million

Previous $25.2 Million 10.06%

% of portfolio

0.41%

Previous 0.38%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $35,471 - $43,106	135 Added 0.15%	88,640 $27.7 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $357,328 - $431,340	-1,329 Reduced 1.48%	88,505 $25.2 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $610,867 - $689,130	2,389 Added 2.73%	89,834 $25.9 Million
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $881,815 - $1.09 Million	4,033 Added 4.84%	87,445 $23.5 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $15,641 - $18,496	73 Added 0.09%	83,412 $18.5 Million
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $422,678 - $515,174	-1,872 Reduced 2.2%	83,339 $20.1 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $6.84 Million - $8.69 Million	29,853 Added 53.93%	85,211 $22.4 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $862,599 - $972,855	3,843 Added 7.46%	55,358 $12.5 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $474,801 - $528,370	2,058 Added 4.16%	51,515 $12.5 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $323,423 - $357,790	1,475 Added 3.07%	49,457 $12 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $600,020 - $686,669	-3,017 Reduced 5.92%	47,982 $10.8 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $574,402 - $672,982	-2,706 Reduced 5.04%	50,999 $10.8 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $515,978 - $572,440	-2,209 Reduced 3.95%	53,705 $13.1 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $377,247 - $439,620	1,700 Added 3.14%	55,914 $13.9 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $1.91 Million - $2.28 Million	8,834 Added 19.47%	54,214 $12.5 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $42,002 - $46,710	179 Added 0.4%	45,380 $11.5 Million
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $2.45 Million - $3 Million	12,364 Added 37.65%	45,201 $10.7 Million
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $586,630 - $778,032	3,219 Added 10.87%	32,837 $6.66 Million
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $148,529 - $190,912	785 Added 2.72%	29,618 $7.14 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $21,763 - $26,077	125 Added 0.44%	28,833 $5.58 Million
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $19,837 - $23,253	-119 Reduced 0.41%	28,708 $5.29 Million
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $12,841 - $14,475	-71 Reduced 0.25%	28,827 $5.48 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $103,472 - $120,785	580 Added 2.05%	28,898 $5.63 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $1.4 Million - $1.58 Million	-7,574 Reduced 21.1%	28,318 $5.87 Million
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $1.18 Million - $1.32 Million	-7,103 Reduced 16.52%	35,892 $6.63 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $452,886 - $529,254	-2,673 Reduced 5.85%	42,995 $7.33 Million
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $144,315 - $161,244	-855 Reduced 1.84%	45,668 $7.94 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $7.78 Million - $8.89 Million	46,523	46,523 $8.68 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Amgen Inc Transaction History